Page last updated: 2024-09-03

3-methyl-2-(3-pyridyl)-1-indoleoctanoic acid and iloprost

3-methyl-2-(3-pyridyl)-1-indoleoctanoic acid has been researched along with iloprost in 1 studies

Compound Research Comparison

Studies
(3-methyl-2-(3-pyridyl)-1-indoleoctanoic acid)
Trials
(3-methyl-2-(3-pyridyl)-1-indoleoctanoic acid)
Recent Studies (post-2010)
(3-methyl-2-(3-pyridyl)-1-indoleoctanoic acid)
Studies
(iloprost)
Trials
(iloprost)
Recent Studies (post-2010) (iloprost)
36112,150271462

Protein Interaction Comparison

ProteinTaxonomy3-methyl-2-(3-pyridyl)-1-indoleoctanoic acid (IC50)iloprost (IC50)
Prostacyclin receptorHomo sapiens (human)0.0112

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Holladay, CS; Spangelo, BL; Wright, RM1

Other Studies

1 other study(ies) available for 3-methyl-2-(3-pyridyl)-1-indoleoctanoic acid and iloprost

ArticleYear
Arachidonic acid stimulates interleukin-6 release from rat peritoneal macrophages in vitro: evidence for a prostacyclin-dependent mechanism.
    Prostaglandins, leukotrienes, and essential fatty acids, 1993, Volume: 49, Issue:6

    Topics: Animals; Arachidonic Acid; Epoprostenol; Iloprost; In Vitro Techniques; Interleukin-6; Kinetics; Macrophages, Peritoneal; Male; Prostaglandins, Synthetic; Pyridines; Rats; Thromboxane A2; Thromboxane-A Synthase

1993